Clinical trial
Hydralazine as a Demethylating Agent in Rectal Cancer
NCT00575640 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydralazine as a Demethylating Agent in Rectal Cancer
- Lead sponsor
- University of Arkansas
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- November 30, 2004
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer